Roger Perlmutter lures Roy Baynes away from Merck; Now, Voyager: Al Sandrock becomes a CEO after break from Biogen
→ Professional sports teams cycle through free agency every year, and core veterans from championship clubs routinely splinter off in different directions. In a similar vein, Merck in particular has seen widespread turnover with its own nucleus of talent that helped Keytruda become one of the biggest blockbusters in the industry, whether it’s CEO Ken Frazier passing the baton to Rob Davis or chief marketing officer Mike Nally taking the helm at Flagship’s Generate Biomedicines. Another big name at the pharma giant, Merck Research Laboratories CMO Roy Baynes, has decided to move on himself — and he’ll be back with an old teammate.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.